Champions Oncology (CSBR) Revenue (2010 - 2026)
Champions Oncology (CSBR) revenue from Jul 31, 2010 to Jan 31, 2026. The TTM Champions Oncology (CSBR) revenue is $58M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Revenue
Quarterly Revenue
Champions Oncology (CSBR) Revenue CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | -1.08% |
| 3 Years TTM | +12.31% |
| 5 Years TTM | +8.12% |
Annual Revenue change of Champions Oncology (CSBR)
| Year | Revenue | Change |
|---|---|---|
| 2026 | $17M | -70.92% |
| 2025 | $57M | +13.52% |
| 2024 | $50M | -6.89% |
| 2023 | $54M | +9.69% |
| 2022 | $49M | +19.66% |
| 2021 | $41M | +27.77% |
| 2020 | $32M | +18.66% |
| 2019 | $27M | +33.75% |
| 2018 | $20M | N/A |
| 2017 | $0 | N/A |
| 2016 | $0 | N/A |
| 2015 | $0 | N/A |
| 2014 | $0 | N/A |
| 2013 | $0 | N/A |
| 2012 | $0 | N/A |
| 2011 | $0 | N/A |
| 2010 | $0 | N/A |
Comparison Champions Oncology (CSBR) five years revenue CAGR with competitors
Champions Oncology (CSBR) five years revenue CAGR is 9.14%.